SG11202104813VA - Monohydrate potassium salt of a thienopyridone derivative and its preparation process - Google Patents

Monohydrate potassium salt of a thienopyridone derivative and its preparation process

Info

Publication number
SG11202104813VA
SG11202104813VA SG11202104813VA SG11202104813VA SG11202104813VA SG 11202104813V A SG11202104813V A SG 11202104813VA SG 11202104813V A SG11202104813V A SG 11202104813VA SG 11202104813V A SG11202104813V A SG 11202104813VA SG 11202104813V A SG11202104813V A SG 11202104813VA
Authority
SG
Singapore
Prior art keywords
preparation process
potassium salt
monohydrate potassium
thienopyridone derivative
thienopyridone
Prior art date
Application number
SG11202104813VA
Inventor
Sébastien Bolze
Marc Lanz
Deniz Arican
Anthony O'sullivan
Sophie Hallakou-Bozec
Laure Navarre
Original Assignee
Poxel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Poxel filed Critical Poxel
Publication of SG11202104813VA publication Critical patent/SG11202104813VA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
SG11202104813VA 2018-11-16 2019-11-18 Monohydrate potassium salt of a thienopyridone derivative and its preparation process SG11202104813VA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18306505 2018-11-16
PCT/EP2019/081650 WO2020099678A1 (en) 2018-11-16 2019-11-18 Monohydrate potassium salt of a thienopyridone derivative and its preparation process

Publications (1)

Publication Number Publication Date
SG11202104813VA true SG11202104813VA (en) 2021-06-29

Family

ID=64564771

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202104813VA SG11202104813VA (en) 2018-11-16 2019-11-18 Monohydrate potassium salt of a thienopyridone derivative and its preparation process

Country Status (13)

Country Link
US (1) US20220017532A1 (en)
EP (1) EP3880683B1 (en)
JP (1) JP7266676B2 (en)
CN (1) CN113166168A (en)
AU (1) AU2019379797A1 (en)
BR (1) BR112021009270A2 (en)
CA (1) CA3118974A1 (en)
IL (1) IL282444B1 (en)
MX (1) MX2021005772A (en)
PH (1) PH12021551091A1 (en)
SG (1) SG11202104813VA (en)
WO (1) WO2020099678A1 (en)
ZA (1) ZA202103209B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115361949A (en) * 2020-04-02 2022-11-18 博希尔公司 Use of thienopyridone derivatives in the treatment of autosomal dominant polycystic kidney disease ADPKD

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1754483A1 (en) * 2005-08-18 2007-02-21 Merck Sante Use of thienopyridone derivatives as AMPK activators and pharmaceutical compositions containing them
CN101998853B (en) * 2008-04-11 2015-02-11 默克专利有限公司 Thienopyridone derivatives as AMP-activated protein kinase (AMPK) activators
EP2679591A1 (en) 2012-06-29 2014-01-01 Poxel Thienopyridone derivatives useful as activators of AMPK

Also Published As

Publication number Publication date
US20220017532A1 (en) 2022-01-20
BR112021009270A2 (en) 2021-08-10
EP3880683B1 (en) 2023-11-01
MX2021005772A (en) 2021-10-13
EP3880683C0 (en) 2023-11-01
ZA202103209B (en) 2023-08-30
AU2019379797A1 (en) 2021-05-20
EP3880683A1 (en) 2021-09-22
JP7266676B2 (en) 2023-04-28
IL282444A (en) 2021-06-30
KR20210081368A (en) 2021-07-01
CA3118974A1 (en) 2020-05-22
IL282444B1 (en) 2024-03-01
WO2020099678A1 (en) 2020-05-22
CN113166168A (en) 2021-07-23
JP2022507558A (en) 2022-01-18
PH12021551091A1 (en) 2021-12-13

Similar Documents

Publication Publication Date Title
RS62759B1 (en) One-pot process for the preparation of racemic nicotine by reaction of ethyl nicotinate with n-vinylpyrrolidone in the presence of sodium ethanolate or potassium ethanolate or mixtures thereof
EP3383844B8 (en) Process for the preparation of carboprost and its tromethamine salt
IL269626A (en) Crystalline salt forms of boc-d-arg-dmt-lys-(boc)-phe-nh2
PT3640239T (en) Pharmaceutically acceptable salt of alkylcarbamoyl naphthalenyloxy octenoylhydroxyamide or of derivative thereof and method for preparing same
IL284912A (en) L-valinate of hydroxypropylthiazolidine carboxamide derivative and salt form, crystal polymorph thereof
EP3621974A4 (en) A process for the preparation of sglt2 inhibitors and intermediates thereof
IL272108A (en) New crystalline forms of vilanterol trifenatate and processes for their preparation
IL254709B (en) Novel and useful edible salt and methods of use and production thereof
IL282444A (en) Monohydrate potassium salt of a thienopyridone derivative and its preparation process
PT3725786T (en) Crystal form and salt form of tgf-bri inhibitor and preparation method therefor
ZA202004055B (en) Salt of phenylpropionamide derivative and preparation method therefor
ZA201706480B (en) A process for the preparation of methionine alpha-hydroxy analogues from sugars and derivatives thereof
GB201610867D0 (en) Crystalline forms of a therapeutic compound and processes for their preparation
EP3837239A4 (en) Process for the preparation of solriamfetol and salt thereof
EP3508478A4 (en) Salt derivative of tetrahydroisoquinoline and crystalline thereof and preparation method therefor and application thereof
GB2603328B (en) Process for the synthesis of elagolix sodium salt and intermediates of said process
IL277578A (en) Novel salt forms of urat-1 inhibitors
EP3434678A4 (en) Salt form of dppiv inhibitor and preparation method for salt form
EP3511317A4 (en) New crystalline form of sacubitril sodium salt
EP3453741A4 (en) Aqueous-solvent solution of imide-group-containing compound and production method for aqueous-solvent solution of imide-group-containing compound
EP3508479A4 (en) Crystal forms of valsartan disodium salt
HUP1800089A2 (en) Process for the preparation of the b polymorph form of treprostinil-diethanol-amine salt
EP3848360A4 (en) Salt of cyclohexane derivative
IL273540A (en) Crystalline forms of diazabicyclooctane derivatives and production process thereof
PT3632909T (en) Salt and crystal form of modified andrographolide compound and preparation method thereof